Wednesday, April 21, 2021 12:51:36 PM
This is a method for finding and selecting cancers to treat, and how to treat trough the NR2F6 pathway, it's basically a packaged up revenue stream, a blueprint for a huge pharmaceutical company to make personalized cancer treatments for people through NR2F6. A company can use this to and model it, it's all spelled out for them. Huge HUGE potential here. This is how RGBP thinks, it's brilliant to obtain multiple patents to license or sell, all proprietary. Hardly any overhead on them after paying their experts to find labs to prove and exact their experts' theories, then obtain the patents. They don't need to pay for lab equipment! It's a genius model to go after these HUGE sectors of biomed and do what they do. Don't forget! This is a startup! GET IN ON THE GROUND FLOOR!
https://patents.google.com/patent/US9091696B2/en
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM